Similarly, Gan et al. [58] demonstrated that the knockdown of cathepsin D contributed to a decrease in inflammation-mediated dopaminergic neurodegeneration via inhibition of the NF-κB signaling pathway in a PD mouse model. Here, CTSD is linked to Parkinson disease.